Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease.
about
Ivermectin - Old Drug, New Tricks?Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.Coherent anti-Stokes Raman scattering (CARS) spectroscopy in Caenorhabditis elegans and Globodera pallida: Evidence for an ivermectin-activated decrease in lipid stores.Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin.The nuclear melatonin receptor RORα is a novel endogenous defender against myocardial ischemia/reperfusion injury.
P2860
Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@ast
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@en
type
label
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@ast
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@en
prefLabel
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@ast
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@en
P2093
P2860
P356
P1433
P1476
Selective targeting of nuclear ...... alcoholic fatty liver disease.
@en
P2093
P2860
P2888
P356
10.1038/SREP17288
P407
P577
2015-12-01T00:00:00Z